Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

Articles published in
Int J Oncol
    May 2024
  1. AI L, Yi N, Qiu C, Huang W, et al
    Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review).
    Int J Oncol. 2024;64:46.
    >> Share

    April 2024
  2. ZHANG W, Tang X, Peng Y, Xu Y, et al
    GBP2 enhances paclitaxel sensitivity in triple?negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway.
    Int J Oncol. 2024;64:34.
    >> Share

  3. MBUGUA RW, Takano A, Tsevegjav B, Yokose T, et al
    Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer.
    Int J Oncol. 2024;64:43.
    >> Share

    March 2024
  4. LI Z, Yu D, Li H, Lv Y, et al
    [Corrigendum] Long non?coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway.
    Int J Oncol. 2024;64:23.
    >> Share

  5. HE Y, Ma Y, Zhu Y, Zhang J, et al
    HDAC inhibitors target IRS4 to enhance anti?AR therapy in AR?positive triple?negative breast cancer.
    Int J Oncol. 2024;64:25.
    >> Share

  6. JIN Y, Zhao M, Xie Q, Zhang H, et al
    [Retracted] MicroRNA?338?3p functions as tumor suppressor in breast cancer by targeting SOX4.
    Int J Oncol. 2024;64:21.
    >> Share

    February 2024
  7. LIU H, Li M, Lin Y, You H, et al
    Dual?directional effect of vinorelbine combined with cisplatin or fluorouracil on tumor growth and metastasis in metronomic chemotherapy in breast cancer.
    Int J Oncol. 2024;64:13.
    >> Share

  8. WANG YY, Cheng KH, Hung AC, Lo S, et al
    Differential impact of cytoplasmic vs. nuclear RAD51 expression on breast cancer progression and patient prognosis.
    Int J Oncol. 2024;64:12.
    >> Share

    December 2023
  9. KAUSAR MA, Anwar S, El-Horany HE, Khan FH, et al
    Journey of CAR T?cells: Emphasising the concepts and advancements in breast cancer (Review).
    Int J Oncol. 2023;63:130.
    >> Share

    October 2023
  10. SONG J, Tang Y, Song F
    Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation.
    Int J Oncol. 2023;63:111.
    >> Share

    September 2023
  11. WANG M, Wu Y, Li X, Dai M, et al
    IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF‑kappaB signaling pathway.
    Int J Oncol. 2023;63:105.
    >> Share

    July 2023
  12. WANG S, Huang M, Wang Z, Wang W, et al
    [Corrigendum] MicroRNA‑133b targets TGFbeta receptor I to inhibit TGF‑beta‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑beta/SMAD pathway in breast cancer.
    Int J Oncol. 2023;63:83.
    >> Share

    June 2023
  13. JIN H, Ko YS, Yun SP, Park SW, et al
    P2Y(2)R‑mediated transactivation of VEGFR2 through Src phosphorylation is associated with ESM‑1 overexpression in radiotherapy‑resistant‑triple negative breast cancer cells.
    Int J Oncol. 2023;62:73.
    >> Share

    April 2023
  14. XU L, Han F, Zhu L, Ding W, et al
    Advances in understanding the role and mechanisms of tumor stem cells in HER2-positive breast cancer treatment resistance (Review).
    Int J Oncol. 2023;62:48.
    >> Share

    March 2023
  15. OKUI T, Hiasa M, Hasegawa K, Nakamura T, et al
    Lactate secreted via MCT4 from bone‑colonizing breast cancer excites sensory neurons via GPR81.
    Int J Oncol. 2023;62:39.
    >> Share

    February 2023
  16. HAGAN ML, Mander S, Joseph C, McGrath M, et al
    Upregulation of the EGFR/MEK1/MAPK1/2 signaling axis as a mechanism of resistance to antiestrogen‑induced BimEL dependent apoptosis in ER(+) breast cancer cells.
    Int J Oncol. 2023;62:20.
    >> Share

    January 2023
  17. ZHOU H, Gan M, Jin X, Dai M, et al
    [Corrigendum] miR382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumorassociated macrophages by targeting PGC1alpha.
    Int J Oncol. 2023;62.
    >> Share

    December 2022
  18. WU H, Guo X, Jiao Y, Wu Z, et al
    TRIM35 ubiquitination regulates the expression of PKM2 tetramer and dimer and affects the malignant behaviour of breast cancer by regulating the Warburg effect.
    Int J Oncol. 2022;61.
    >> Share

  19. ZHANG Y, Liang Y, Wang Y, Ye F, et al
    A novel ferroptosisrelated gene signature for overall survival prediction and immune infiltration in patients with breast cancer.
    Int J Oncol. 2022;61.
    >> Share

  20. MENG Z, Zhang R, Wu X, Zhang M, et al
    PDL1 mediates triplenegative breast cancer evolution via the regulation of TAM/M2 polarization.
    Int J Oncol. 2022;61.
    >> Share

    October 2022
  21. KATSUTA E, Gil-Moore M, Moore J, Yousif M, et al
    Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors.
    Int J Oncol. 2022;61.
    >> Share

  22. ZHAO Y, Pang W, Yang N, Hao L, et al
    [Retracted] MicroRNA511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway.
    Int J Oncol. 2022;61.
    >> Share

  23. ZHOU H, Gan M, Jin X, Dai M, et al
    miR382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumorassociated macrophages by targeting PGC1alpha.
    Int J Oncol. 2022;61.
    >> Share

    August 2022
  24. DONG H, Wang W, Chen R, Zhang Y, et al
    [Retracted] Exosome-mediated transfer of lncRNASNHG14 promotes trastuzumab chemoresistance in breast cancer.
    Int J Oncol. 2022;61.
    >> Share

  25. ZHANG X, Ge X, Jiang T, Yang R, et al
    Research progress on immunotherapy in triplenegative breast cancer (Review).
    Int J Oncol. 2022;61.
    >> Share

    May 2022
  26. ZHAO L, Li Y, He M, Song Z, et al
    [Retracted] The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNKp53dependent mitochondrial apoptosis in breast cancer cells.
    Int J Oncol. 2022;60.
    >> Share

  27. LAVORO A, Scalisi A, Candido S, Zanghi GN, et al
    Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
    Int J Oncol. 2022;60.
    >> Share

    April 2022
  28. MENG Q, Zhou L, Liang H, Hu A, et al
    Spinespecific downregulation of LAPTM5 expression promotes the progression and spinal metastasis of estrogen receptorpositive breast cancer by activating glutaminedependent mTOR signaling.
    Int J Oncol. 2022;60.
    >> Share

    February 2022
  29. BAKKER EY, Fujii M, Krstic-Demonacos M, Demonacos C, et al
    Protein disulfide isomerase A1associated pathways in the development of stratified breast cancer therapies.
    Int J Oncol. 2022;60.
    >> Share

    January 2022
  30. LEE A, Jin HO, Masudul Haque M, Kim HY, et al
    Synergism of a novel MCL1 downregulator, acriflavine, with navitoclax (ABT263) in triplenegative breast cancer, lung adenocarcinoma and glioblastoma multiforme.
    Int J Oncol. 2022;60.
    >> Share

  31. MAAROUF A, Boissard A, Henry C, Leman G, et al
    Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapyinduced senescence escape.
    Int J Oncol. 2022;60.
    >> Share

    November 2021
  32. KITAYAMA K, Kawamoto T, Kawakami Y, Hara H, et al
    Regulatory roles of miRNAs 16, 133a, and 223 on osteoclastic bone destruction caused by breast cancer metastasis.
    Int J Oncol. 2021;59.
    >> Share

  33. VIETRI MT, D'Elia G, Benincasa G, Ferraro G, et al
    DNA methylation and breast cancer: A way forward (Review).
    Int J Oncol. 2021;59.
    >> Share

    March 2021
  34. TAKENAGA K, Ochiya T, Endo H
    Inhibition of the invasion and metastasis of mammary carcinoma cells by NBD peptide targeting S100A4 via the suppression of the Sp1/MMP14 axis.
    Int J Oncol. 2021;58:397-408.
    >> Share

  35. GUI C, Zhang C, Xiong X, Huang J, et al
    Total flavone extract from Ampelopsis megalophylla induces apoptosis in the MCF7 cell line.
    Int J Oncol. 2021;58:409-418.
    >> Share

    January 2021
  36. LI J, Shi K, Xu T, Hu J, et al
    Mechanisms regulating DMTF1beta/gamma expression and their functional interplay with DMTF1alpha.
    Int J Oncol. 2021;58:20-32.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016